Yep - it's not easy to find positive points out of the outlook.
One of the first things I did this morning after reading the report is to check on the update from Pacific Smiles (the service and facilities provider to dental practitioners). They reported, among other things, a "slight softening in patient attendances during September and October" linked to "ongoing macroeconomic headwinds and reduced consumer sentiment associated with cost of living pressures".
So, I'm at least happy to assume that there is a general trend running against them rather than their downturn in revenue being attributable to a loss of market share, albeit that the lucky break with amalgam sales has run its race.
The Gross Profit margin improvement was an essential achievement given that the freight cost issues that diluted their margin initially have since been largely extinguished.
Operating costs increased by 3.4% which may also include some costs linked to the changes to facilities and equipment which will hopefully result in cost reductions down the line.
- Forums
- ASX - By Stock
- SDI
- Ann: 2023 AGM CEO's Presentation
Ann: 2023 AGM CEO's Presentation, page-3
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SDI (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.03 |
Change
0.000(0.00%) |
Mkt cap ! $121.8M |
Open | High | Low | Value | Volume |
$1.03 | $1.03 | $1.03 | $2 | 2 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 10370 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.03 | 48721 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 10370 | 1.020 |
1 | 2 | 1.015 |
3 | 1154 | 1.005 |
3 | 21548 | 1.000 |
2 | 31479 | 0.960 |
Price($) | Vol. | No. |
---|---|---|
1.025 | 48721 | 1 |
1.030 | 7749 | 2 |
1.035 | 100000 | 2 |
1.045 | 4500 | 1 |
1.055 | 3000 | 1 |
Last trade - 10.08am 12/11/2024 (20 minute delay) ? |
Featured News
SDI (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online